---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-048257"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-04-28T23:59:59+00:00"
generated_at: "2026-05-15T02:43:44.581493+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# 20/20 Biolabs cuts warrant exercise price to $2.25, from $11.42/$8.00

## Summary
- On April 23, 2026, amended Streeterville warrants lowering exercise price to $2.25/share.
- Warrants cover 3,627,627 shares; prior prices were $11.42 and $8.00.
- Company retains right to terminate amendment within 90 days on 2 days' notice.
- Warrants issued in conjunction with $5M+ in convertible notes and Series E preferred.
- Reduction implies significant potential dilution for existing common shareholders.

## SEC filing metadata
- accession: 0001213900-26-048257
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-04-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026048257/0001213900-26-048257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026048257/ea0287933-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-048257
- JSON: https://secwatch.observer/filing/0001213900-26-048257.json
- Plain text: https://secwatch.observer/filing/0001213900-26-048257.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.